OROPHARYNX CANCER, RECURRENT
Clinical trials for OROPHARYNX CANCER, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX CANCER, RECURRENT trials appear
Sign up with your email to follow new studies for OROPHARYNX CANCER, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for throat cancer: testing a powerful immune drug against standard treatment
Disease control OngoingThis study is testing whether a newer immunotherapy drug (pembrolizumab) combined with radiation works better than the current standard treatment of chemotherapy plus radiation for people with advanced head and neck cancer. It will involve 126 patients whose cancer is linked to t…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Phase: PHASE2 • Sponsor: Loren Mell, MD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could a simple blood test catch Cancer's return?
Diagnosis OngoingThis study is testing if a blood test that looks for cancer DNA can find throat cancer when it comes back after treatment. It involves 200 patients who have been treated for a specific type of throat cancer linked to HPV. The goal is to see if this blood test works better or fast…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Sponsor: Rigshospitalet, Denmark • Aim: Diagnosis
Last updated Mar 16, 2026 15:26 UTC